Indexado en

Licencia y uso

Citaciones

Cited 2 times in

Cited 2 times in

Altmetrics

Grant support

This work was promoted and sponsored by the Spanish Menopause Society. Statistical analyses were conducted by Manuel Monroy and Miguel Ruiz from the Universidad Autonoma de Madrid, and was funded by Pfizer, S.L.U. No editorial support was provided except for a review of the English, conducted by Your English Lab.

Análisis de autorías institucional

Compartir

Predictive and criterion validity of the Cervantes-SF menopause quality of life questionnaire

Publicado en:MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY. 28 (8): 935-942 - 2021-01-01 28(8), DOI: 10.1097/GME.0000000000001790

Autores: Coronado, Pluvio J.; Monroy, Manuel; Fasero, Maria; Baquedano, Laura; Mendoza, Nicolas; Llaneza, Placido; Rejas, Javier; Ruiz, Miguel A.;

Afiliaciones

Resumen

Objectives: To determine the predictive and criterion-based validity of the Cervantes-SF scale that measures the impact of menopause on Health-Related Quality of Life. Methods: We recruited a noninstitutionalized sample of peri/postmenopausal women aged 40 to 65 years, who had their last menstrual cycle 12+ months prior to inclusion in the study of the psychometric validity of the Cervantes-SF scale. Predictive validity of the scale was confirmed for various health outcome measures administered concomitantly (years of disability-free life expectancy, work productivity and impact on daily activities, economic impact arising from loss of work productivity, hours of undisturbed sleep each day, and the utilization of healthcare facilities), whilst criterion validity was determined by the likelihood of identifying a moderate-to-severe vasomotor or genital syndrome requiring specific treatment. Results: A sample of 308 peri/postmenopausal women with a mean age of 55.7 years (SD: 5.3 y) was analyzed in this study. A score >25 points on the dimension of vasomotor problems (or menopausal health) showed values of sensitivity and specificity > 80% for identifying women with moderate-severe vasomotor syndrome requiring pharmacological treatment. Predictive validity was confirmed for menopause-related health outcomes. A change of 6.7 points in the scale score, equivalent to the value of its minimal difference, is indicative of a significant increase in the degree of disability regarding work/day-to-day activities, greater economic loss due to decreased work productivity, fewer years of life expectancy without disability, fewer hours of undisturbed sleep, and more visits to the physician per year due to menopausal symptoms. Conclusions: These results confirm the criterion and predictive validity of the Cervantes-SF scale in peri/postmenopausal women.

Palabras clave